Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT01306110
NCT01306110CompletedNot Applicable

Screening for Liver Fibrosis by Using Non-invasive Methods in Patients With Diabetes. A Prospective Study

Association HGE CHU Bordeaux Sud1 site in 1 country277 target enrollmentStarted: June 2007Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
277
Locations
1
Study OverviewStudy DesignEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The aim of this study is to evaluate liver fibrosis using FibroScan and biochemical markers in patients with diabetes.

Detailed Description

Patients with diabetes are at risk for nonalcoholic fatty liver disease (NAFLD) leading to advanced fibrosis, cirrhosis, and liver cancer. However, liver fibrosis screening in this large population needs non-invasive methods. Recently, FibroScan was shown to be a good method for the diagnosis of advanced fibrosis in NAFLD patients. We examined the efficacy of a screening strategy with a noninvasive fibrosis biomarker (FibroTest) and transient elastography (FibroScan) in patients with diabetes.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Male or female subjects
  • •More than 18 years of age
  • •Patients with Diabetes
  • •Written informed consent

Exclusion Criteria

  • •Patients refusing to participate to the study and to provide written informed consent

Investigators

Sponsor
Association HGE CHU Bordeaux Sud
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

de Ledinghen

Professor

Association HGE CHU Bordeaux Sud

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Prospective Evaluation of FibroScan in Patients Treated With MethotrexateLiver Fibrosis
NCT00673101Association HGE CHU Bordeaux Sud1,871
Recruiting
Not Applicable
Rapid Breath-hold Quantitative Macromolecular Proton Fraction Imaging for Liver FibrosisLiver Fibrosis
NCT04429100Chinese University of Hong Kong200
Completed
Not Applicable
Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis BChronic Hepatitis B
NCT01679769Peking University First Hospital818
Unknown
Not Applicable
Screening for Liver Fibrosis by Using Non-invasive Methods ( Fibro Scan) in Patients With Elevated Liver EnzymesElevated Liver Enzymes
NCT01784484Assy Nimer
Terminated
Not Applicable
Methods to Detect Liver FibrosisLiver FibrosesHepatic Steatosis
NCT03027700Children's Hospital Medical Center, Cincinnati6
Screening for Liver Fibrosis by Using... | Clinical Trial